Worldwide, the 2019 Coronavirus Disease (COVID-19) has significantly increased morbidity and mortality. Pre-immunosuppression and other co morbidities can have an impact on COVID-19 results in transplant patients. The Kidney Transplant Recipients (KTRs) in this single center prospective cohort study were those who underwent a kidney transplant between kidney transplant between December 2012 and November 2020, were monitored at our facility, and obtained a diagnosis of COVID-19 disease between April 1 and November 30, 2020. Patients who have received a kidney transplant are significantly more likely to get COVID-19 due to their immunosuppression. Initial signs and symptoms are similar in COVID-19 positive KTRs and the general population. KTRs have a higher mortality rate than the overall population.
